Study on the pharmacokinetics, tissue distribution and excretion of laurolitsine from Litsea glutinosa in Sprague-Dawley rats

Context Laurolitsine is an aporphine alkaloid and exhibits potent antihyperglycemic and antihyperlipidemic effects in ob/ob mice. Objective To investigate the pharmacokinetics, tissue distribution and excretion of laurolitsine. Materials and methods A LC-MS/MS method was established and validated to...

Full description

Bibliographic Details
Main Authors: Yin-Feng Tan, Rui-Qi Wang, Wen-Ting Wang, Ying Wu, Ning Ma, Wei-Ying Lu, Yong Zhang, Xiao-Po Zhang
Format: Article
Language:English
Published: Taylor & Francis Group 2021-01-01
Series:Pharmaceutical Biology
Subjects:
Online Access:http://dx.doi.org/10.1080/13880209.2021.1944221
_version_ 1818654920161624064
author Yin-Feng Tan
Rui-Qi Wang
Wen-Ting Wang
Ying Wu
Ning Ma
Wei-Ying Lu
Yong Zhang
Xiao-Po Zhang
author_facet Yin-Feng Tan
Rui-Qi Wang
Wen-Ting Wang
Ying Wu
Ning Ma
Wei-Ying Lu
Yong Zhang
Xiao-Po Zhang
author_sort Yin-Feng Tan
collection DOAJ
description Context Laurolitsine is an aporphine alkaloid and exhibits potent antihyperglycemic and antihyperlipidemic effects in ob/ob mice. Objective To investigate the pharmacokinetics, tissue distribution and excretion of laurolitsine. Materials and methods A LC-MS/MS method was established and validated to determine laurolitsine concentrations in the biological matrix of rats (plasma, tissue homogenate, urine and faeces). 10 Sprague-Dawley (SD) rats were used for plasma exposure study: 5 rats were injected with 2.0 mg/kg of laurolitsine via the tail vein, and the other 5 rats were administered laurolitsine (10.0 mg/kg) by gavage. 25 SD rats used for tissue distribution study and 5 SD rats for urine and faeces excretion study: rats administered laurolitsine (10.0 mg/kg) by gavage. After administered, serial blood, tissue, urine and faeces were collected. Analytical quantification was performed by a previous LC-MS/MS method. The pharmacokinetics, bioavailability, tissue distribution and excretion of laurolitsine were described. Results The pharmacokinetic parameters of oral and intravenous administration with Tmax were 0.47 and 0.083 h, t1/2 were 3.73 and 1.67 h, respectively. Oral bioavailability was as low as 18.17%. Laurolitsine was found at a high concentration in the gastrointestinal tract, liver, lungs and kidneys (26 015.33, 905.12, 442.32 and 214.99 ng/g at 0.5 h, respectively) and low excretion to parent laurolitsine in urine and faeces (0.03 and 1.20% in 36 h, respectively). Conclusions This study established a simple, rapid and accurate LC-MS/MS method to determine laurolitsine in different rat samples and successful application in a pharmacokinetic study.
first_indexed 2024-12-17T03:01:27Z
format Article
id doaj.art-b8e4a5bb56d64d64991e19619c2a9e4d
institution Directory Open Access Journal
issn 1388-0209
1744-5116
language English
last_indexed 2024-12-17T03:01:27Z
publishDate 2021-01-01
publisher Taylor & Francis Group
record_format Article
series Pharmaceutical Biology
spelling doaj.art-b8e4a5bb56d64d64991e19619c2a9e4d2022-12-21T22:06:04ZengTaylor & Francis GroupPharmaceutical Biology1388-02091744-51162021-01-0159188489210.1080/13880209.2021.19442211944221Study on the pharmacokinetics, tissue distribution and excretion of laurolitsine from Litsea glutinosa in Sprague-Dawley ratsYin-Feng Tan0Rui-Qi Wang1Wen-Ting Wang2Ying Wu3Ning Ma4Wei-Ying Lu5Yong Zhang6Xiao-Po Zhang7Key Laboratory of Tropical Translational Medicine of Ministry of Education, Hainan Key Laboratory for Research and Development of Tropical Herbs, School of Pharmacy, Hainan Medical UniversityKey Laboratory of Tropical Translational Medicine of Ministry of Education, Hainan Key Laboratory for Research and Development of Tropical Herbs, School of Pharmacy, Hainan Medical UniversityReproductive Medical Center, Hainan Women and Children’s Medical CenterReproductive Medical Center, Hainan Women and Children’s Medical CenterReproductive Medical Center, Hainan Women and Children’s Medical CenterReproductive Medical Center, Hainan Women and Children’s Medical CenterDepartment of Pharmacology, Hainan Medical UniversityKey Laboratory of Tropical Translational Medicine of Ministry of Education, Hainan Key Laboratory for Research and Development of Tropical Herbs, School of Pharmacy, Hainan Medical UniversityContext Laurolitsine is an aporphine alkaloid and exhibits potent antihyperglycemic and antihyperlipidemic effects in ob/ob mice. Objective To investigate the pharmacokinetics, tissue distribution and excretion of laurolitsine. Materials and methods A LC-MS/MS method was established and validated to determine laurolitsine concentrations in the biological matrix of rats (plasma, tissue homogenate, urine and faeces). 10 Sprague-Dawley (SD) rats were used for plasma exposure study: 5 rats were injected with 2.0 mg/kg of laurolitsine via the tail vein, and the other 5 rats were administered laurolitsine (10.0 mg/kg) by gavage. 25 SD rats used for tissue distribution study and 5 SD rats for urine and faeces excretion study: rats administered laurolitsine (10.0 mg/kg) by gavage. After administered, serial blood, tissue, urine and faeces were collected. Analytical quantification was performed by a previous LC-MS/MS method. The pharmacokinetics, bioavailability, tissue distribution and excretion of laurolitsine were described. Results The pharmacokinetic parameters of oral and intravenous administration with Tmax were 0.47 and 0.083 h, t1/2 were 3.73 and 1.67 h, respectively. Oral bioavailability was as low as 18.17%. Laurolitsine was found at a high concentration in the gastrointestinal tract, liver, lungs and kidneys (26 015.33, 905.12, 442.32 and 214.99 ng/g at 0.5 h, respectively) and low excretion to parent laurolitsine in urine and faeces (0.03 and 1.20% in 36 h, respectively). Conclusions This study established a simple, rapid and accurate LC-MS/MS method to determine laurolitsine in different rat samples and successful application in a pharmacokinetic study.http://dx.doi.org/10.1080/13880209.2021.1944221aporphine alkaloidlc-ms/ms
spellingShingle Yin-Feng Tan
Rui-Qi Wang
Wen-Ting Wang
Ying Wu
Ning Ma
Wei-Ying Lu
Yong Zhang
Xiao-Po Zhang
Study on the pharmacokinetics, tissue distribution and excretion of laurolitsine from Litsea glutinosa in Sprague-Dawley rats
Pharmaceutical Biology
aporphine alkaloid
lc-ms/ms
title Study on the pharmacokinetics, tissue distribution and excretion of laurolitsine from Litsea glutinosa in Sprague-Dawley rats
title_full Study on the pharmacokinetics, tissue distribution and excretion of laurolitsine from Litsea glutinosa in Sprague-Dawley rats
title_fullStr Study on the pharmacokinetics, tissue distribution and excretion of laurolitsine from Litsea glutinosa in Sprague-Dawley rats
title_full_unstemmed Study on the pharmacokinetics, tissue distribution and excretion of laurolitsine from Litsea glutinosa in Sprague-Dawley rats
title_short Study on the pharmacokinetics, tissue distribution and excretion of laurolitsine from Litsea glutinosa in Sprague-Dawley rats
title_sort study on the pharmacokinetics tissue distribution and excretion of laurolitsine from litsea glutinosa in sprague dawley rats
topic aporphine alkaloid
lc-ms/ms
url http://dx.doi.org/10.1080/13880209.2021.1944221
work_keys_str_mv AT yinfengtan studyonthepharmacokineticstissuedistributionandexcretionoflaurolitsinefromlitseaglutinosainspraguedawleyrats
AT ruiqiwang studyonthepharmacokineticstissuedistributionandexcretionoflaurolitsinefromlitseaglutinosainspraguedawleyrats
AT wentingwang studyonthepharmacokineticstissuedistributionandexcretionoflaurolitsinefromlitseaglutinosainspraguedawleyrats
AT yingwu studyonthepharmacokineticstissuedistributionandexcretionoflaurolitsinefromlitseaglutinosainspraguedawleyrats
AT ningma studyonthepharmacokineticstissuedistributionandexcretionoflaurolitsinefromlitseaglutinosainspraguedawleyrats
AT weiyinglu studyonthepharmacokineticstissuedistributionandexcretionoflaurolitsinefromlitseaglutinosainspraguedawleyrats
AT yongzhang studyonthepharmacokineticstissuedistributionandexcretionoflaurolitsinefromlitseaglutinosainspraguedawleyrats
AT xiaopozhang studyonthepharmacokineticstissuedistributionandexcretionoflaurolitsinefromlitseaglutinosainspraguedawleyrats